血清IL-12、IL-10及IL-18与肺结核的相关性研究

Correlation of Serum IL-12, IL-10 and IL-18 and TB

目的探讨肺结核患者对血清白细胞介素-12(IL-12)、白细胞介素-10(IL-10)和白细胞介素-18(IL-18)表达的影响,并分析血清IL-12、IL-10和IL-18与肺结核的相关性。方法随机选择首次复治肺结核80例为复治组,初治肺结核120例为初治组,体检健康100例为对照组;分别检测三组的血IL-12、IL-10和IL-18水平,并比较三组血清IL-12、IL-10和IL-18水平与临床意义。结果治疗前,复治组血清IL-12、IL-10和IL-18水平均明显高于初治组、对照组,差异均有统计学意义(P<0.05);初治组血清IL-12、IL-10和IL-18水平均与对照组比较,差异均有统计学意义(P<0.05);治疗后,三组的血清IL-12、IL-10和IL-18水平均比较,差异均无有统计学意义(P>0.05)。结论 IL-12、IL-10和IL-18参与了肺结核的发生、发展,检测相关血清炎症因子水平有助于对肺结核疾病变化过程和治疗功效的评估。

Objective To investigate the effects of tuberculosis patients serum interleukin-12（IL-12）, interleukin-10 （IL-10） and interleukin-18（IL-18） expression in and of serum IL-12, IL-10 and IL-18 with tuberculosis relevance. Methods Randomly select the first 80 cases of pulmonary tuber-culosis retreatment group, 120 cases of pulmonary tuberculosis for initial treatment group, 100 cases of physical health for the control group; blood were detected three groups of IL-12, IL-10 and IL-18 levels and compared three groups of serum IL-12, IL-10 and IL-18 levels and clinical significance proposed. Results Before treatment, the retreatment group serum IL-12, IL-10 and IL-18 levels were significantly higher than the initial treatment group and the control group, which differences were statistically significant （P＆lt;0.05）; the Initial treatment group serum IL-12, IL-10 and IL-18 levels were compared with control group, which differences were statistically sig-nificant （P＆lt;0.05）; after treatment, the three groups of serum IL-12, IL-10 and IL-18 levels were compared with the differences there was no statistically significant（P＆gt;0.05）. Conclusions IL-12, IL-10 and IL-18 involved in the incidence of tuberculosis, development, testing related to serum lev-els of inflammatory factors contribute to the assessment of pulmonary disease and therapeutic effi-cacy of the change process.